| Air France-KLM renews Marjan Rintel's mandate as President & CEO of KLM | Paris, February 2, 2026 Air France-KLM renews Marjan Rintel's mandate as President & CEO of KLM Air France-KLM's Board of Directors today approved the renewal of Marjan Rintel's mandate as President... ► Artikel lesen |
| RBC stuft AIR FRANCE-KLM auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Bewertung von Air France-KLM mit "Sector Perform" und einem Kursziel von 11,50 Euro neu aufgenommen. Ruairi Cullinane sieht laut seiner... ► Artikel lesen |
| BERNSTEIN RESEARCH stuft AIR FRANCE-KLM auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Air France-KLM auf "Market-Perform" mit einem Kursziel von 11,50 Euro belassen. Die Nachfrage auf den Nordatlantikstrecken... ► Artikel lesen |
| Koninklijke Vopak N.V.: Vopak reports strong performance, driven by a resilient portfolio | The Netherlands, 5 November 2025 Vopak reports strong performance, driven by a resilient portfolioKey highlights Improve Net profit -including exceptional items- increased YTD Q3 2025 by 30% to... ► Artikel lesen |
| Koninklijke Vopak N.V.: Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm | Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm Muscat, Oman - 27 October 2025 - Oman Tank Terminal Company (OTTCO), a subsidiary... ► Artikel lesen |
| Falcker and Vopak signed an agreement for worldwide deployment of Falcker's advanced tank inspection platform | DELFT, Netherlands, Oct. 8, 2025 /PRNewswire/ -- Inspection and maintenance software specialist, Falcker, and Vopak, the leader in tank storage and infrastructure solutions, have signed... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day | Highlights advancing clinical-stage pipeline, including two major value-creating programs for primary immunodeficiencies (PIDs) with immune dysregulation and mtDNA-driven mitochondrial diseaseIntroduces... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja (leniolisib) in children aged 4 to 11 years with APDS | Leiden, the Netherlands, February 1, 2026: Pharming Group (Euronext: PHARM; Nasdaq: PHAR) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)... ► Artikel lesen |
| Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy | Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
21.01.2026 / 16:13 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen |